Earnings News

Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.

CeriBell Boosts 2026 Forecast on AI EEG Adoption, Loss Widens
Earnings James Calloway

CeriBell Boosts 2026 Forecast on AI EEG Adoption, Loss Widens

CeriBell lifts 2026 revenue forecast to $114M-$117M after Q2 sales rose 33%, but net loss widened 41% to $19.3M as expenses outpaced growth.

CBLL
Simon Property Raises 2026 FFO Forecast on Strong Tenant Sales
Earnings James Calloway

Simon Property Raises 2026 FFO Forecast on Strong Tenant Sales

Simon Property Group (SPG) raised its 2026 FFO guidance after a strong Q2, with tenant sales up 13.9% and base rent up 6.3%. Occupancy held at 96%.

Sandisk Shares Climb as Analysts Reassess Post-Earnings Drop
Earnings James Calloway

Sandisk Shares Climb as Analysts Reassess Post-Earnings Drop

Sandisk shares rose 1.9% on Monday as analysts reframed last week's earnings selloff, with Argus upgrading to Buy and a $1,600 target.

SNDK WDC MU STX
CEVA Stock Plunges 16% as Royalty Growth Trails AI Licensing Boom
Earnings James Calloway

CEVA Stock Plunges 16% as Royalty Growth Trails AI Licensing Boom

CEVA shares tumbled 16% after Q2 results showed a licensing surge but royalty growth of only 1%, as AI design wins have yet to generate production revenue.

CEVA
UnitedHealth's Optum Health Beats 2026 Profit Goal, Investors Eye 2027 Growth
Earnings James Calloway

UnitedHealth's Optum Health Beats 2026 Profit Goal, Investors Eye 2027 Growth

Optum Health reported $2.486B in adjusted operating earnings for H1 2026, beating its full-year minimum target by 12%, but investors look to 2027 for sustained growth.

UNH JPM MS UBS HSBC HUM ELV CI CVS
Quanterix Plunges 39% on Revised Guidance, Delayed Breakeven
Earnings James Calloway

Quanterix Plunges 39% on Revised Guidance, Delayed Breakeven

Quanterix (QTRX) dropped 39% after lowering 2026 revenue guidance and delaying cash-flow breakeven to 2027. Q2 revenue rose 34% but margins were mixed.

QTRX
Berkshire Shares Hit Record as Buffett Successor Ramps Up $28B Capital Push
Earnings James Calloway

Berkshire Shares Hit Record as Buffett Successor Ramps Up $28B Capital Push

Berkshire Hathaway (BRK.B) shares surged to an all-time high after Q2 operating earnings jumped 16.3% and new CEO Greg Abel deployed $28 billion in capital.

BRK.B GOOGL AAPL
Embraer Soars 5.7% on Record Q2 Revenue, Tax Relief Drives Margin Outlook
Earnings James Calloway

Embraer Soars 5.7% on Record Q2 Revenue, Tax Relief Drives Margin Outlook

Embraer (EMBJ) climbed 5.7% after record Q2 revenue and an improved 2026 outlook, with tax and tariff relief accounting for 96% of the EBIT guidance increase.

EVEX
Walmart's Q2 Margin Expansion Faces Investor Scrutiny
Earnings James Calloway

Walmart's Q2 Margin Expansion Faces Investor Scrutiny

Walmart heads into its Aug. 20 earnings with a growth-stock valuation, but margin expansion and e-commerce profitability will be key tests.

WMT COST TGT KR
CoreWeave Stock Surges 26% as Earnings Test Looms
Earnings James Calloway

CoreWeave Stock Surges 26% as Earnings Test Looms

CoreWeave (NASDAQ:CRWV) shares jump 26% this week as investors await Q2 earnings. The company faces margin pressure and high leverage, with options pricing a 13% move.

CRWV NBIS LITE AMAT
IonQ Beats Q2 Estimates but H2 Revenue Growth Looks Flat
Earnings James Calloway

IonQ Beats Q2 Estimates but H2 Revenue Growth Looks Flat

IonQ (NYSE:IONQ) reported Q2 revenue of $80.1M, beating estimates, and raised its 2026 guidance. However, implied H2 revenue suggests only marginal growth, with shares up 11.9%.

IONQ QBTS RGTI JPM
Rocket Lab and AST SpaceMobile Rise Premarket Ahead of Q2 Earnings
Earnings James Calloway

Rocket Lab and AST SpaceMobile Rise Premarket Ahead of Q2 Earnings

Rocket Lab and AST SpaceMobile shares rose in premarket trading ahead of their Q2 earnings reports. ASTS faces a challenging revenue target for the second half.

RKLB ASTS